Awarded
NHS National Framework Agreement for the Supply of Generic Pharmaceuticals — Interim 1 2020
Descriptions
NHS national framework agreement for the supply of generic pharmaceuticals — Interim 1 2020. Offer reference number: CM/PHG/20/5589 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months). Potential periods of call-offs under the framework agreement Hospital Only Products: DLS/DNE/DNW 1 August 2020 to 31 July 2021 (12 months), DLN/DCE/DSW 1 August 2020 to 31 July 2021 (12 months). Products on the framework include (but are not limited to): — Darunavir — Disodium Pamidronate — Doxorubicin — Epirubicin — Ethambutol — Etoposide — Glycopyrronium Bromide — Ibuprofen — Irinotecan — Lopinavir/Ritonavir — Milrinone — Posaconazole — Ritonavir — Salbutamol — Tramadol — Vancomycin. Details of presentation sizes and volumes are within the tender document set.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
UK
CPV Codes
33690000 - Various medicinal products
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
diverse pharmaceuticals
general drug products
healthcare medications
assorted therapeutic agents
medical product range
Tender Lot Details
2 Tender Lots
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
